Statin use is associated with the reduction in hepatocellular carcinoma recurrence after liver surgery

Hepatocellular carcinoma (HCC) is the sixth most common form of cancer worldwide. Although surgical treatments have an acceptable cure rate, tumor recurrence is still a challenging issue. In this meta-analysis, we investigated whether statins prevent HCC recurrence following liver surgery.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Khajeh, Elias (VerfasserIn) , Dooghaie Moghadam, Arash (VerfasserIn) , Eslami, Pegah (VerfasserIn) , Ali-Hasan-Al-Saegh, Sadeq (VerfasserIn) , Ramouz, Ali (VerfasserIn) , Shafiei, Saeed (VerfasserIn) , Ghamarnejad, Omid (VerfasserIn) , Abbasi Dezfouli, Sepehr (VerfasserIn) , Rupp, Christian (VerfasserIn) , Springfeld, Christoph (VerfasserIn) , Carvalho, Carlos (VerfasserIn) , Probst, Pascal (VerfasserIn) , Mousavizadeh, Seyed Mostafa (VerfasserIn) , Mehrabi, Arianeb (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 21 January 2022
In: BMC cancer
Year: 2022, Jahrgang: 22, Pages: 1-9
ISSN:1471-2407
DOI:10.1186/s12885-022-09192-1
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12885-022-09192-1
Volltext
Verfasserangaben:Elias Khajeh, Arash Dooghaie Moghadam, Pegah Eslami, Sadeq Ali-Hasan-Al-Saegh, Ali Ramouz, Saeed Shafiei, Omid Ghamarnejad, Sepehr Abbasi Dezfouli, Christian Rupp, Christoph Springfeld, Carlos Carvalho, Pascal Probst, Seyed Mostafa Mousavizadeh and Arianeb Mehrabi
Beschreibung
Zusammenfassung:Hepatocellular carcinoma (HCC) is the sixth most common form of cancer worldwide. Although surgical treatments have an acceptable cure rate, tumor recurrence is still a challenging issue. In this meta-analysis, we investigated whether statins prevent HCC recurrence following liver surgery.
Beschreibung:Gesehen am 11.08.2022
Beschreibung:Online Resource
ISSN:1471-2407
DOI:10.1186/s12885-022-09192-1